首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial
【24h】

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial

机译:放化疗与化学疗法对吉西他滨4个月合并或不合并厄洛替尼的局部晚期胰腺癌患者生存率的影响LAP07随机临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of erlotinib is unknown.
机译:重要在局部晚期胰腺癌中,放化疗的作用尚存争议,厄洛替尼的疗效尚不清楚。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号